ATYPICAL HEMOLYTIC SYNDROME INDUCED BY PEMBROLIZUMAB. MANAGEMENT AND OUTCOMES.

  Back

14 Apr 2024 5:45 p.m. 6:45 p.m.

WCN24-AB-1486, Poster Board= SUN-005

Natallia Maroz Poster Presenter